
Oncternal Therapeutics ONCT
Oncternal Therapeutics DPO | ONCT
DPO Jährlich Oncternal Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | 422 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 422 | 422 | 422 |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aclaris Therapeutics
ACRS
|
1.56 K | $ 5.32 | 0.09 % | $ 652 M | ||
|
ADC Therapeutics SA
ADCT
|
856 | $ 1.05 | 0.46 % | $ 133 M | ||
|
Agenus
AGEN
|
25.8 K | $ 7.21 | 0.7 % | $ 214 M | ||
|
Фармсинтез
LIFE
|
306 | - | - | - | ||
|
Akebia Therapeutics
AKBA
|
168 | $ 0.92 | 1.64 % | $ 237 M | ||
|
Alector
ALEC
|
13.8 | $ 1.93 | 0.81 % | $ 199 M | ||
|
Alkermes plc
ALKS
|
143 | $ 46.07 | 0.09 % | $ 7.59 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
55 | $ 239.36 | 0.46 % | $ 31.4 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
31.7 | $ 23.95 | 1.31 % | $ 1.12 B | ||
|
Anika Therapeutics
ANIK
|
43.4 | $ 20.84 | 0.24 % | $ 299 M | ||
|
ANI Pharmaceuticals
ANIP
|
57.9 | $ 73.59 | 2.05 % | $ 1.48 B | ||
|
Aptevo Therapeutics
APVO
|
239 | $ 1.72 | 0.58 % | $ 543 K | ||
|
Aquestive Therapeutics
AQST
|
395 | $ 4.82 | 0.21 % | $ 515 M | ||
|
AbbVie
ABBV
|
65.5 | $ 262.51 | 0.01 % | $ 464 B | ||
|
Aurinia Pharmaceuticals
AUPH
|
47.5 | $ 16.96 | 5.15 % | $ 2.28 B | ||
|
Autolus Therapeutics plc
AUTL
|
9.57 | $ 1.87 | 0.53 % | $ 498 M | ||
|
Axon Enterprise
AXON
|
34.3 | $ 468.42 | 5.96 % | $ 36.6 B | ||
|
Axsome Therapeutics
AXSM
|
529 | $ 211.97 | 3.87 % | $ 10.5 B | ||
|
Aytu BioScience
AYTU
|
186 | $ 1.97 | 0.5 % | $ 12.4 M | ||
|
BridgeBio Pharma
BBIO
|
399 | $ 68.3 | 0.1 % | $ 13.1 B | ||
|
Biogen
BIIB
|
65 | $ 216.01 | 0.42 % | $ 31.6 B | ||
|
Benitec Biopharma
BNTC
|
-556 | $ 11.04 | 0.9 % | $ 514 M | ||
|
Clovis Oncology
CLVS
|
236 | - | -7.23 % | $ 13 M | ||
|
Chimerix
CMRX
|
2.38 K | - | - | $ 756 M | ||
|
Catalyst Biosciences
CBIO
|
7.82 | $ 17.18 | 1.7 % | $ 1.53 B |